A study of serum magnesium levels in patients with type 2 diabetes mellitus, hypertension, dyslipidemia, coronary artery disease and correlation with ASCVD risk score.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 162
- 试验地点
- 1
- 主要终点
- Outcome expected in this study would be whether low magnesium levels in blood is associated with Type 2 Diabetes Mellitus, Hypertension, Dyslipidemia and Coronary artery disease and its correlation with ASCVD risk score. Hence there may be a role of magnesium supplementation in preventing these diseases.
研究概览
简要总结
In this study we would like to measure Serum magnesium levels in patients with diabetes mellitus(DM), hypertension(HTN) ,Dyslipidemia and in CAD and correlate the magnesium levels range in quartiles and show that magnesium levels are lower in these group of individuals with more severe disease than less severe disease. Hence comes the role of Magnesium supplementation in prevention of Type 2 Diabetes, Hypertension, Dyslipidemia and CAD and may have a protective role against these diseases. Also ASCVD risk score shall be calculated for all patients who have Diabetes, Hypertension and Dyslipidemia and ASCVD risk shall be estimated and also correlate whether low magnesium is associated with higher ASCVD risk score.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40.00 Year(s) 至 79.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with Type 2 DM, HTN, Dyslipidemia and CAD and in the age group of 40 to 79 yrs.
排除标准
- •Patients who are having chronic kidney disease, chronic liver disease, endocrinopathy, rheumatologic diseases, magnesium supplements, antacids, diuretics and chronic alcoholic will be excluded.
结局指标
主要结局
Outcome expected in this study would be whether low magnesium levels in blood is associated with Type 2 Diabetes Mellitus, Hypertension, Dyslipidemia and Coronary artery disease and its correlation with ASCVD risk score. Hence there may be a role of magnesium supplementation in preventing these diseases.
时间窗: Day 1
次要结局
- Magnesium levels in only diabetics, magnesium levels in diabetes with hypertension, magnesium levels in diabetes with hypertension and dyslipidemia.(Day 1)